🔎 Trials Near Me

Akèy › Timè Wilms › New York

Etid klinik pou Timè Wilms nan New York

6 etid pou Timè Wilms ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • New York Medical College, Valhalla
Ap rekriteFaz 2
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • Albany Medical Center, Albany
  • Roswell Park Cancer Institute, Buffalo
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
  • ak 9 plis
Ap rekriteFaz 2
Jiska laj 30 · Tout sèks · Mizajou Aug 25, 2026 · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
  • ak 1 plis
Ap rekriteFaz 2
12 Months · Tout sèks · Mizajou May 6, 2026 · NCT05985161

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

  • New York Medical College, Valhalla
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Apr 15, 2026 · NCT04308330

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital at Montefiore, The Bronx
Ap rekriteFaz 2
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.